Margaux Lecacheur

6PUBLICATIONS
27CO-AUTHORS
Microelectromechanical systems (MEMS)Autonomic nervous systemToxicology (incl. clinical toxicology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 13, 2026
Extracellular matrix stiffness determines the phenotypic behavior of dedifferentiated melanoma cells through a DDR1/2-dependent YAP mechanotransduction pathway.

|Mar 12, 2026
NAD+ controls circadian rhythmicity during cardiac aging.

Bryce J Carpenter, Margaux Lecacheur, Yannick N Mangold

|Mar 15, 2023
PIP4K2B is mechanoresponsive and controls heterochromatin-driven nuclear softening through UHRF1.

Alessandro Poli, Fabrizio A Pennacchio, Andrea Ghisleni

|May 03, 2022
Secretion of IL1 by Dedifferentiated Melanoma Cells Inhibits JAK1-STAT3-Driven Actomyosin Contractility of Lymph Node Fibroblastic Reticular Cells.

Christopher Rovera, Ilona Berestjuk, Margaux Lecacheur

|Feb 14, 2022
Blockade of the pro-fibrotic reaction mediated by the miR-143/-145 cluster enhances the responses to targeted therapy in melanoma.

Serena Diazzi, Alberto Baeri, Julien Fassy

|Dec 27, 2021
Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix-mediated tumor cell adaptation and tolerance to BRAF-targeted therapy in melanoma.

Ilona Berestjuk, Margaux Lecacheur, Alexandrine Carminati

Pageof 1

Frequent Collaborators

4 joint publications

Marcel Deckert

4 joint publications

Sophie Tartare-Deckert

3 joint publications

Virginie Prod'homme

2 joint publications

Mickael Ohanna